In co-transfection experiments with full-length PTK6 and ALT-PTK6, Brauer et al. demonstrated the inhibitory effects of ALT-PTK6 on the phosphorylation of PTK6 in prostate cancer cell lines [40]. Here, PTK6 is linked to prostate carcinoma.